CIM INVESTMENT MANAGEMENT INC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1179791
PITTSBURGH, PA
Position in LGND
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$296,280
+$24,965 QoQ
Shares Held
1,484
+3.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIM INVESTMENT MANAGEMENT INC holds $2,638,068 across 8 Biotechnology names. LGND ranks #6 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,930 | $558,131 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
8,492 | $548,837 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
452 | $349,233 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
14,239 | $316,960 | |
| 5 | CYTK |
Cytokinetics Inc
|
4,678 | $308,326 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
This page
|
1,484 | $296,280 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,993 | $260,301 | |
| 8 | 12,537 | $0 |
All Filings in LGND
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $296,280 | 1,484 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $271,315 | 1,435 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $254,195 | 1,435 | Shares | Sole | 2025-11-18 | |
| 2021-12-31 | $221,650 | 1,435 | Shares | Sole | 2022-05-19 | |
| 2021-06-30 | $282,714 | 2,155 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $243,254 | 2,446 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $233,152 | 2,446 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $269,558 | 2,410 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||